Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 20, Pages 4597-4607
Publisher
American Society of Hematology
Online
2012-03-04
DOI
10.1182/blood-2011-10-388298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- Should there be a standard therapy for mantle cell lymphoma?
- (2011) Mitchell R Smith Future Oncology
- A Pilot Study to Evaluate 3'-Deoxy-3'-18F-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma
- (2011) K. Herrmann et al. JOURNAL OF NUCLEAR MEDICINE
- Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
- (2010) P. Perez-Galan et al. BLOOD
- A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
- (2010) Marta Puyol et al. CANCER CELL
- Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line
- (2010) R. Chen et al. CANCER RESEARCH
- Mantle cell lymphoma: The promise of new treatment options
- (2010) Andre Goy et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
- (2010) J L Dean et al. ONCOGENE
- Treatment of Growing Teratoma Syndrome
- (2009) David J. Vaughn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation
- (2009) Tara Barwick et al. NUCLEAR MEDICINE COMMUNICATIONS
- Frontline therapy in mantle cell lymphoma: The role of high-dose therapy and integration of new agents
- (2009) Brad S. Kahl Current Hematologic Malignancy Reports
- A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model
- (2008) E. Menu et al. CANCER RESEARCH
- Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
- (2008) Annina Herrmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging of Cell Proliferation: Status and Prospects
- (2008) J. R. Bading et al. JOURNAL OF NUCLEAR MEDICINE
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
- (2007) E. Hoster et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started